David Reardon, MD

Professor, Medicine, Harvard Medical School; Clinical Director, Center for Neuro-Oncology, Medical Oncology, Dana-Farber Cancer Institute.

Return to Leadership

Contact us

Corporate

Alpheus Medical, Inc.
1266 Park Road
Chanhassen, MN 55317
info@alpheusmedical.com

Legal

Investigational Use Disclaimer

Sonodynamic Therapy (SDT) is an investigational therapy and has not been approved by the U.S. Food and Drug Administration. Safety and efficacy have not been established.

Medical Disclaimer

The information on this website is for informational purposes only and is not intended as medical advice. Patients should always consult qualified healthcare professionals about diagnosis or treatment options.

Forward-Looking Statement

This website may contain forward-looking statements based on current expectations that involve risks and uncertainties. Actual results may differ materially. Nothing on this site constitutes an offer to sell or the solicitation of an offer to buy any securities.

California Declaration of Compliance

Alpheus Medical, Inc. declares that, to the best of its knowledge, it is in compliance with the requirements of California Health & Safety Code §§ 119400–119402 concerning the marketing of pharmaceutical products and has developed a Comprehensive Compliance Program consistent with the U.S. Department of Health and Human Services Office of Inspector General’s Compliance Program Guidance for Pharmaceutical Manufacturers and the PhRMA Code. To request a copy, please contact compliance@alpheusmedical.com.

© 2025 Alpheus Medical Inc., All Rights Reserved. This site is intended for U.S. audiences only. Privacy Policy | Terms of Use

Roger Stupp, MD